Genetic Test Could Help Many Women With Breast Cancer Safely Skip Chemotherapy, Major Trial Finds

A major trial shows a DNA-based tumour test can help two-thirds of eligible women with early hormone-driven breast cancer safely avoid chemotherapy, cutting harsh side-effects without significantly affecting survival. Learn how the Prosigna gene test works, who it’s for, and what it means for future breast cancer treatment.